found that conventional methylprednisolone effectively reduced DNT cells, but not IL-17-producing DNT cells, in patients with autoantibody-associated vasculitis (AAV) (37). This evidence concerns the gene IL17A and anti-neutrophil cytoplasmic antibody-associated vasculitis.